blood-based mutation testing: circulating tumor cells and tumor dna
Published 8 years ago • 526 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
5:13
serum testing for molecular markers: circulating tumor cells & circulating free dna
-
7:40
gracecast - lcvl - can blood-based mutation-testing help shape treatment decisions for advanced nscl
-
1:48
circulating tumor dna (ctdna) and overtreatment in nsclc - onctalk lung 2023
-
3:11
grace targeted therapies in lung cancer 2021 - circulating tumor dna testing replace marker testing?
-
1:59:57
grace - global resource for advancing cancer education live stream
-
5:14
onctalk 2021 - circulating tumor dna for minimal residual disease
-
1:36
gracecastuc-073_lung_will new forms of mutation testing be available beyond major research centers?
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
4:00
is it possible to test lung tumors without doing a biopsy?
-
4:55
the importance of biomarker testing: what is liquid biopsy?
-
4:46
liquid biopsies: faster results, easier on patients
-
21:19
repeat biopsies & emerging technologies for plasma sampling of mutations
-
8:29
liquid vs. tissue biopsies to detect t790m mutations
-
4:35
the importance of biomarker testing: what is liquid biopsy? - targeted therapies in lung cancer 2023
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
3:07
third generation egfr tkis for acquired resistance
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
27:28
blood tests for cancer
-
3:41
what is a biomarker? - bladder cancer video library